Hoppa till innehåll
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avancerad
  • Tumour expression of the DNA r...
  • Hänvisa
  • Textmeddelande
  • Skicka per e-post
  • Skriv ut
  • Exportera posten
    • Exportera till: RefWorks
    • Exportera till: EndNoteWeb
    • Exportera till: EndNote
  • Permanent länk
Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

Bibliografiska uppgifter
Huvudupphovsmän: Gillies, R, Delaney, D, Warren, B, Sharma, R, Middleton, MR
Materialtyp: Conference item
Publicerad: 2011
  • Beståndsuppgifter
  • Beskrivning
  • Liknande verk
  • Katalogiseringsuppgifter

Liknande verk

  • Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
    av: Gillies, R, et al.
    Publicerad: (2012)
  • Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.
    av: Gillies, R, et al.
    Publicerad: (2012)
  • XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
    av: Hatch, S, et al.
    Publicerad: (2014)
  • Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity
    av: Graf, Nora, et al.
    Publicerad: (2012)
  • Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
    av: MacGregor, T, et al.
    Publicerad: (2018)

Sökalternativ

  • Sökhistorik
  • Avancerad sökning

Sök mera

  • Bläddra i katalogen
  • Bläddra alfabetiskt
  • Utforska kanaler
  • Kursböcker
  • Nytt i katalogen

Behöver du hjälp?

  • Söktips
  • Fråga biblioteket
  • Vanliga frågor